Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis
- DOI
- 10.1016/j.breast.2021.02.009
- Published
- 2021-06
- Container
- The Breast
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.breast.2021.02.009,
title = {Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis},
author = {Elizabeth M. Salvo and Abril Oliva Ramirez and Jenilee Cueto and Ernest H. Law and Aaron Situ and Chris Cameron and Imtiaz A. Samjoo},
year = {2021},
journal = {The Breast},
doi = {10.1016/j.breast.2021.02.009},
url = {https://doi.org/10.1016/j.breast.2021.02.009}
}RIS
TY - JOUR TI - Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis AU - Elizabeth M. Salvo AU - Abril Oliva Ramirez AU - Jenilee Cueto AU - Ernest H. Law AU - Aaron Situ AU - Chris Cameron AU - Imtiaz A. Samjoo PY - 2021 JO - The Breast DO - 10.1016/j.breast.2021.02.009 UR - https://doi.org/10.1016/j.breast.2021.02.009 ER -
APA
Salvo, E. M., Ramirez, A. O., Cueto, J., Law, E. H., Situ, A., Cameron, C., & Samjoo, I. A. (2021). Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis. The Breast. https://doi.org/10.1016/j.breast.2021.02.009
Source records
- crossref · retrieved 2026-09-26T09:41:14.288Z